This company listing is no longer active
Emplicure Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Emplicure's earnings have been declining at an average annual rate of -36.9%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 48.3% per year.
Anahtar bilgiler
-36.9%
Kazanç büyüme oranı
-7.1%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 30.5% |
| Gelir büyüme oranı | 48.3% |
| Özkaynak getirisi | -129.7% |
| Net Marj | 19,935.0% |
| Son Kazanç Güncellemesi | 30 Sep 2023 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Emplicure nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -27 | 26 | 0 |
| 30 Jun 23 | 1 | -26 | 25 | 0 |
| 31 Mar 23 | 1 | -29 | 25 | 0 |
| 31 Dec 22 | 1 | -30 | 24 | 0 |
| 30 Sep 22 | 1 | -26 | 8 | 0 |
| 31 Mar 22 | 0 | -24 | 10 | 0 |
| 31 Dec 21 | 0 | -18 | 6 | 0 |
| 30 Sep 21 | 0 | -15 | 11 | 0 |
| 31 Dec 20 | 0 | -5 | 2 | 0 |
Kaliteli Kazançlar: EMPLI is currently unprofitable.
Büyüyen Kar Marjı: EMPLI is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: Insufficient data to determine if EMPLI's year-on-year earnings growth rate was positive over the past 5 years.
Büyüme Hızlandırma: Unable to compare EMPLI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: EMPLI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.8%).
Özkaynak Getirisi
Yüksek ROE: EMPLI has a negative Return on Equity (-129.73%), as it is currently unprofitable.